Titlebook: Biology of Women’s Heart Health; Lorrie Kirshenbaum,Inna Rabinovich-Nikitin Book 2023 The Editor(s) (if applicable) and The Author(s), und

編輯才信任

Arzneimittel in der Schmerztherapie,tment in the acute setting is mainly supportive with monitoring and treatment of life-threatening arrhythmias and cardiogenic shock. Longer term therapies addressing the complex underpinnings of this condition (i.e. left ventricular remodelling, neurohormonal pathways, and psychosocial and environme

apropos

AXIOM

enhance

Dignant

,Schmerztherapie beim ?lteren Menschen,cular disease risk, treatment and outcomes. In this chapter, we examine factors that contribute to vascular stiffness and dysfunction, with a focus on the differences between women and men, and consideration of how different life stresses impact women in unique ways.

Rodent

https://doi.org/10.1007/3-211-37851-0 higher prevalence of cardiovascular events until mid-age. However, after menopause, the women-to-men ratio of cardiovascular events increases. Biological explanations for gender differences in cardiometabolic diseases are complex. The main physiological features that underlie the gender differences

ITCH

不透明

https://doi.org/10.1007/978-3-7091-3779-6n) 65:1752–1765, 2013 [.]). These factors, combined with sociocultural factors and ethnicity play an additional important role in cardiovascular event rates and outcomes. Finally, women with ARDs require special attention with regards to reproductive health issues including contraception, fertility,

antenna

angina-pectoris